Huddinge, Sweden

Xiongyu Wu

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Xiongyu Wu: Innovator in Estrogen Receptor Ligands

Introduction

Xiongyu Wu is a notable inventor based in Huddinge, Sweden. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that interact with estrogen receptors. With a total of 2 patents, his work has implications for the treatment of various diseases and disorders associated with estrogen receptor activity.

Latest Patents

Xiongyu Wu's latest patents focus on substituted pyrazoles as estrogen receptor ligands. The invention provides a compound of formula (I) wherein G is a pyrazole ring as defined in the specification, and R, R, R, and R are also defined in the specification. These compounds can exist as pharmaceutically acceptable esters, amides, solvates, or salts, including salts of such esters or amides. The invention also outlines the use of these compounds in the treatment or prophylaxis of conditions associated with estrogen receptor activity.

Career Highlights

Throughout his career, Xiongyu Wu has worked with prominent companies in the pharmaceutical industry, including Karo Bio AB and Karo Pharma AB. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug development.

Collaborations

Xiongyu Wu has collaborated with several professionals in his field, including Joakim Löfstedt and Lars Krüger. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Xiongyu Wu's contributions to the field of medicinal chemistry, particularly through his patents on estrogen receptor ligands, highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of estrogen-related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…